Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company specializing in the development of novel immunotherapies for cancer treatment. Utilizing proprietary ADAPTIR and ADAPTIR-FLEX modular protein platforms, it designs monospecific, bispecific, and multispecific antibody-based therapeutics targeting hematologic malignancies and solid tumors. Aptevo’s pipeline includes clinical and preclinical candidates that engage and modulate the immune system to enhance anti-tumor responses, serving oncology markets through innovative biologic drug development.
This description was generated via AI from an annual report. Updated about 1 year ago.